Wall Street Divided on UnitedHealth Stock Ahead of Q3 Earnings
UnitedHealth Group Incorporated (NYSE:UNH) is heading into its third-quarter earnings report on Oct. 13 with Wall Street analysts divided on its outlook. Shares traded down 0.53% to $377.30 ahead of the announcement. Consensus estimates project third-quarter earnings per share of $4.15, representing a 42.1% increase year over year, alongside revenue of $111.31 billion, down roughly 1.6%.
Brokerage opinions highlight contrasting viewpoints regarding the healthcare provider's long-term trajectory. Piper Sandler maintained a Buy rating, citing strength in Medicare Advantage enrollment where roughly 66.8% of members are in contracts rated 4 Stars or higher for 2027. Conversely, TD Cowen kept a Hold rating and lowered its price target from $430 to $402. The firm warned that lower Medicare Star ratings could create a $13 per-member monthly headwind in 2028, amounting to about $1.5 billion in revenue impact.
Investors will look closely at management's forward-looking guidance during the upcoming report. Key metrics to watch include the medical loss ratio, expected around 89.9% for the quarter, Optum Health profitability, and management commentary regarding 2027 earnings growth and Medicare Star rating impacts.
Key points
- Wall Street expects UnitedHealth to report third-quarter EPS of $4.15 on revenue of $111.31 billion.
- Piper Sandler reiterated a Buy rating, highlighting resilient Medicare Advantage ratings for 2027.
- TD Cowen kept a Hold rating and cut its price target to $402, warning of future revenue headwinds.
- Investors are watching the 89.9% projected medical loss ratio and management's 2027 growth outlook.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
When is UnitedHealth Group reporting its Q3 earnings?
UnitedHealth Group is scheduled to report its third-quarter financial results on Oct. 13.
What are Wall Street's expectations for UnitedHealth's Q3 results?
Analysts expect earnings per share of $4.15, up 42.1% year over year, and total revenue of $111.31 billion, down approximately 1.6%.
Why are analysts split on UnitedHealth stock?
Analysts disagree on long-term growth, with some optimistic on Medicare Advantage stability and valuation, while others express concern over lower Star Ratings and potential revenue headwinds in 2028.